Search results
Pfizer reports data from Phase II multiple myeloma treatment trial
Clinical Trials Arena via Yahoo Finance· 5 hours ago"Pfizer reports data from Phase II multiple myeloma treatment trial" was originally created and...
How to Safely Discontinue Multiple Myeloma Maintenance Care
Medscape· 3 days agoNew research suggested that the key to safely discontinuing multiple myeloma maintenance therapy is...
ELREXFIO™ Shows Median Overall Survival of More Than Two Years in People with Relapsed or Refractory...
Morningstar· 3 days agoPfizer Inc. (NYSE: PFE) today announced detailed overall survival (OS) results from the Phase 2 MagnetisMM-3 study of ELREXFIO™ (elranatamab-bcmm) in patients with heavily pretreated relapsed ...
Adding Isatuximab to Standard Backbone Prolongs PFS in Myeloma
MedPage Today· 3 days agoMedPage Today brought together three expert leaders in the field: Moderator...
Immunotherapy to treat cancer gave rise to 2nd cancer in extremely rare case
Live Science via Yahoo News· 4 days agotreatment itself. Known as chimeric antigen receptor (CAR) T-cell therapy, the treatment involves...
Greenwood Capital Associates LLC Has $6.10 Million Stock Holdings in Amgen Inc. (NASDAQ:AMGN)
ETF DAILY NEWS· 4 hours agoGreenwood Capital Associates LLC reduced its position in Amgen Inc. (NASDAQ:AMGN – Free Report) by 0.2% in the 4th quarter, Holdings Channel reports. The institutional investor owned 21,173 ...
2024 Warren Alpert Foundation Prize Honors Four Pi | Newswise
Newswise· 6 days agoThe 2024 Warren Alpert Foundation Prize has been awarded to four scientists whose transformational discoveries led to the creation of chimeric antigen receptor (CAR) T cells, a treatment ...
Gerber LLC Makes New $342,000 Investment in Amgen Inc. (NASDAQ:AMGN)
ETF DAILY NEWS· 5 hours agoGerber LLC bought a new stake in Amgen Inc. (NASDAQ:AMGN – Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission ...
More than 2400 Canadians took to the streets of Toronto to raise an unprecedented $1.63 million for...
Benzinga· 20 hours agoThis inclusive family and dog-friendly walk/run event has raised more than $16 million cumulatively in support of ground-breaking cancer research, treatment, and patient care ...
BeiGene, Ltd. (NASDAQ:BGNE) Short Interest Update
ETF DAILY NEWS· 12 hours agoBeiGene, Ltd. (NASDAQ:BGNE – Get Free Report) saw a large drop in short interest during the month of May. As of May 31st, there was short interest totalling 1,560,000 shares, a drop of 6.6% ...